about
'It's personal to me': A qualitative study of depression in young people with CFS/ME.Managed Activity Graded Exercise iN Teenagers and pre-Adolescents (MAGENTA) feasibility randomised controlled trial: study protocol.Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.Practical management of chronic fatigue syndrome or myalgic encephalomyelitis in childhood.What treatments work for anxiety in children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)? Systematic review.Current treatment approaches for paediatric CFS/ME.Defining the minimally clinically important difference of the SF-36 physical function subscale for paediatric CFS/ME: triangulation using three different methodsUsing the internet to cope with chronic fatigue syndrome/myalgic encephalomyelitis in adolescence: a qualitative studyTreatment preference and recruitment to pediatric RCTs: A systematic reviewInvestigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for aResults of the feasibility phase of the managed activity graded exercise in teenagers and pre-adolescents (MAGENTA) randomised controlled trial of treatments for chronic fatigue syndrome/myalgic encephalomyelitisHow are behavioural interventions delivered to children (5-11 years old): a systematic mapping reviewPhysical activity patterns among children and adolescents with mild-to-moderate chronic fatigue syndrome/myalgic encephalomyelitis"The child's got a complete circle around him". The care of younger children (5-11 years) with CFS/ME. A qualitative study comparing families', teachers' and clinicians' perspectives'
P50
Q33605378-3F681769-44D6-4748-A156-15341412558BQ37101024-B5D0513E-3BF5-409B-A9D5-6CB9B20D75BBQ38937878-F30A3EBF-00E9-4BFD-B8D0-E4D6AD56FA53Q39403214-5B6FC950-BA0A-4CD2-BF9A-E1B461C1CC55Q41581411-5ED9D1DE-6E38-44A2-B960-2C601FB18341Q54966675-05256AEF-BE34-469D-A61F-876F7199CBF5Q57810122-BDBEB41E-D34E-4664-A468-4B6235A1BCEEQ58713381-D8ED56E3-3BA4-482A-99ED-54B2F8451D7DQ64275625-C8869049-5FFB-4416-873E-4863CBB7A81CQ87853286-47402EEE-FF9A-4B2C-B330-5D6F6EDBB24AQ92342493-C3902E1D-B2F0-479C-9CA7-3F0730B13ABCQ92465416-3AC933C9-6C9C-4D10-A13C-29E606E0840EQ92800288-D4C6B60D-1978-4E9C-BDE6-CC5564798312Q96233427-D741F0A1-27EA-40E4-B875-6976EACF5BFC
P50
description
researcher
@en
wetenschapper
@nl
name
Amberly Brigden
@en
Amberly Brigden
@nl
type
label
Amberly Brigden
@en
Amberly Brigden
@nl
prefLabel
Amberly Brigden
@en
Amberly Brigden
@nl
P31
P496
0000-0002-7958-7881